Ratios Revealed: Decoding Diversified Healthcare Trust (DHC)’s Financial Health

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

The closing price of Diversified Healthcare Trust (NASDAQ: DHC) was $3.27 for the day, down -0.61% from the previous closing price of $3.29. In other words, the price has decreased by -$0.61 from its previous closing price. On the day, 0.75 million shares were traded. DHC stock price reached its highest trading level at $3.275 during the session, while it also had its lowest trading level at $3.21.

Ratios:

Our analysis of DHC’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 16.95 and its Current Ratio is at 16.95. In the meantime, Its Debt-to-Equity ratio is 1.45 whereas as Long-Term Debt/Eq ratio is at 1.45.

On December 10, 2020, Wells Fargo Downgraded its rating to Underweight which previously was Equal Weight but kept the price unchanged to $4.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 13 ’24 when Brown Matthew C. bought 2,000 shares for $2.55 per share. The transaction valued at 5,098 led to the insider holds 86,282 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DHC now has a Market Capitalization of 788890816 and an Enterprise Value of 3306261504. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.52 while its Price-to-Book (P/B) ratio in mrq is 0.40. Its current Enterprise Value per Revenue stands at 2.187 whereas that against EBITDA is 13.894.

Stock Price History:

The Beta on a monthly basis for DHC is 2.51, which has changed by 0.006153822 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, DHC has reached a high of $4.24, while it has fallen to a 52-week low of $2.00. The 50-Day Moving Average of the stock is -5.81%, while the 200-Day Moving Average is calculated to be 16.16%.

Shares Statistics:

DHC traded an average of 980.90K shares per day over the past three months and 1002510 shares per day over the past ten days. A total of 241.27M shares are outstanding, with a floating share count of 216.72M. Insiders hold about 10.17% of the company’s shares, while institutions hold 77.30% stake in the company. Shares short for DHC as of 1752537600 were 4937463 with a Short Ratio of 5.03, compared to 1749772800 on 5162524. Therefore, it implies a Short% of Shares Outstanding of 4937463 and a Short% of Float of 3.9800000000000004.

Earnings Estimates

Investors are eagerly awaiting the insights provided by 1.0 analysts currently analyzing and rating the stock of Diversified Healthcare Trust (DHC).The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.21 and low estimates of -$0.21.

Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is -$0.61, with 1 analysts recommending between -$0.61 and -$0.61.

Revenue Estimates

It is expected that $90B in revenue will be generated in the current quarter, according to 2 analysts. It ranges from a high estimate of $387.38M to a low estimate of $378.1M. As of the current estimate, Diversified Healthcare Trust’s year-ago sales were $371.39MFor the next quarter, 2 analysts are estimating revenue of $383.05M. There is a high estimate of $392M for the next quarter, whereas the lowest estimate is $374.09M.

A total of 2 analysts have provided revenue estimates for DHC’s current fiscal year. The highest revenue estimate was $1.57B, while the lowest revenue estimate was $1.52B, resulting in an average revenue estimate of $1.54B. In the same quarter a year ago, actual revenue was $1.5BBased on 2 analysts’ estimates, the company’s revenue will be $1.59B in the next fiscal year. The high estimate is $1.61B and the low estimate is $1.57B.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.